datasheet1_Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.docx by Yue Sun (197395)

“…As for the subgroup analysis, compared with 0.5 mg ozanimod, 1 mg ozanimod is related with a significant reduction of the annualized relapse rate during the treatment period (1 mg ozanimod, 0.18; 0.5 mg ozanimod, 0.24; RR, 0.05 [95% CI, 0.01, 0.09])and a decreased number of new or enlarging T2 lesions over the treatment period (1 mg ozanimod,1.58; 0.5 mg ozanimod, 2.05; RR, 0.49 [95% CI, 0.19, 0.79]). …”

datasheet1_Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.docx by Yue Sun (197395)

“…As for the subgroup analysis, compared with 0.5 mg ozanimod, 1 mg ozanimod is related with a significant reduction of the annualized relapse rate during the treatment period (1 mg ozanimod, 0.18; 0.5 mg ozanimod, 0.24; RR, 0.05 [95% CI, 0.01, 0.09])and a decreased number of new or enlarging T2 lesions over the treatment period (1 mg ozanimod,1.58; 0.5 mg ozanimod, 2.05; RR, 0.49 [95% CI, 0.19, 0.79]). …”

Results of the cyclic test experiment on matrilin 3 mutant tendons. by Katarzyna A. Piróg (490536)

“…<p><b>A</b>) Stress per cycle plot showing a decrease in force needed to extend mutant tendons to the same strain as the wild type controls. …”

ROS production by PBMC-derived monocytes and in the J774A.1 cell line (mouse macrophages) is also reduced by pre-incubation with iron-binding molecules. by Armand Paauw (255206)

“…<p>A) ROS production in PBMC-derived monocytes pre-incubated with yersiniabactin or iron-saturated yersiniabactin. …”

Simulations of the model showing different motility types. by Leonie van Steijn (10142786)

Spike trains, K+ currents and Ca++ concentrations from a model of the distal dendrite, spike generator region of an auditory nerve fiber (ANF). by Mark Ospeck (307276)

“…Outward Shaker K+ current that helps to shape the spike train in part A. Note that Shaker current decreases between spikes. …”

Measurement of the centrifugal particle mass analyzer transfer function by A. Naseri (9407129)

“…TCPMA data were collected for a wide range of CPMA resolutions, flow rates, and mass set points ranging from 2 to 15, 0.3 to 8 LPM, and 0.05 to 100 fg, respectively. …”

Video 1_v1_Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism.mp4 by Wan-Chen Zhang (13841521)

“…During a follow-up period of 3 to 36 months, a total of 1 patient in the open group experienced recurrence at 10 months after surgery and was treated non-surgically.…”

Table_1_Type 2 diabetes attributable to ambient particulate matter pollution: a global burden study from 1990 to 2019.DOCX by Yuyi Sha (18581944)

“…Conversely, regions with high SDI levels like High-income North America demonstrated decreasing trends.</p>Conclusion<p>This study reveals a significant increase in T2D worldwide as a result of APMP from 1990 to 2019, with a particular emphasis on its impact on men, the older adult, and regions with low to middle SDI levels. …”

Table 1_A national population-based study of mortality and risk factors in COVID-19-hospitalized patients in Spain (2020–2021).docx by José-Manuel Ramos-Rincón (10428656)

“…Hospitalization rates dropped from 697/100,000 people to 411/100,000, and in-hospital mortality (IHM) decreased from 16.2 to 11.5% (adjusted odds ratio [AOR]: 0.71, 95% CI: 0.70–0.73, p < 0.001). …”

Fürth with translational diffusion fits MSD of model better than Fürth without translational diffusion. by Leonie van Steijn (10142786)

Table_1_Identification and physiological activity of (methoxymethyl)triphenylphosphonium chloride as a new phytotoxin isolated from Rhizoctonia solani AG-3 TB.docx by Xinchun Li (551742)

“…The pure compound MMC treated at 20 μg/mL, 50 μg/mL, and 100 μg/mL can cause obvious necrosis on leaves, increase active oxygen species (AOS), decrease chlorophyll content, and damage cellular structure. …”

Table_6_CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.DOCX by Xiao Huo (4221133)

“…The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. …”

Table_4_CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.DOCX by Xiao Huo (4221133)

“…The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. …”

Table_2_CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.DOCX by Xiao Huo (4221133)

“…The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. …”

Table_1_CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.DOCX by Xiao Huo (4221133)

“…The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. …”

Table_5_CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.docx by Xiao Huo (4221133)

“…The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. …”

Table_3_CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.DOCX by Xiao Huo (4221133)

“…The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. …”

Image_1_CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.JPEG by Xiao Huo (4221133)

“…The subcutaneous tumor formation rate decreased from 100 to 0% in the EZH2 knockout group. …”

Pathogen load in control and rough box migratory colonies. by Maggie Shanahan (17879479)